Opus Genetics Inc. (IRD)

NASDAQ: IRD · Real-Time Price · USD

0.96

0.02 (2.35%)

At close: May 02, 2025, 3:59 PM

0.97

1.33%

After-hours: May 02, 2025, 04:57 PM EDT

Opus Genetics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-57.53M	-9.99M	17.89M	-56.69M	-24.62M	-6.17M
Depreciation & Amortization	10K	6K	4K	4K	8K	3K
Stock-Based Compensation	3.36M	3.51M	1.81M	1.91M	1.51M	308K
Other Working Capital	6.31M	477K	-190K	-200K	354K	525K
Other Non-Cash Items	25.49M	1.28M	170K	35.22M	15.16M	1.91M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	3.09M	4.08M	-5.55M	181K	1.15M	357K
Operating Cash Flow	-25.58M	-1.11M	14.31M	-19.37M	-6.8M	-3.59M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	-25K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	1.21M	n/a	n/a	-100K	539K	n/a
Investing Cash Flow	1.21M	n/a	n/a	-100K	539K	-25K
Debt Repayment	n/a	n/a	-538K	538K	2.2M	4.71M
Common Stock Repurchased	-79K	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-232K	-248K	-104K	-1.42M	-2.23M	-2K
Financial Cash Flow	4.19M	8.98M	3.79M	27.61M	21.12M	4.7M
Net Cash Flow	-20.18M	7.87M	18.1M	8.13M	14.86M	1.09M
Free Cash Flow	-25.58M	-1.11M	14.31M	-19.37M	-6.8M	-3.62M